Swedish mitral valve repair company CardioMech said today that it named medical device industry veteran Richard Nehm as president & CEO effective immediately.
Nehm’s resume includes stints at Boston Scientific (NYSE:BSX), Abbott (NYSE:ABT) acquisition Tendyne and ATS Medical (acquired by Medtronic (NYSE:MDT)). CardioMech also named Spinal Stabilization Technologies president & CEO Mark Novotny as chairman.
“There are more than 400,000 patients around the world that suffer from a leaky mitral valve due to prolapse or flail that are at a high-risk for a cardiac surgery. We are pleased to welcome Rick and Mark to help us accelerate the development of our catheter-based technology that is designed to treat these patients with a transfemoral/transseptal access without the risks associated with open-heart surgery, cardiac arrest and the heart-lung bypass machine,” co-founder & chief medical officer Dr. Jacob Bergsland said in prepared remarks.
“I am thrilled to join this extraordinary team and lead CardioMech down the path towards commercialization of this profound technology. Our objective is to significantly improve the standard of care for very sick patients suffering with mitral valve prolapse and flail,” Nehm added.
“Transcatheter chordal repair is a hot segment with two exits in the last 11 months. The CardioMech device is highly differentiated, and we will build significant shareholder value in a short period of time. I am excited to join this team and guide this exceptional technology to market,” Novotny said.
Read more
Vascular Insights promoted James “Chip” Draper to president & CEO, replacing James Ott, who was named chairman.
Read more
Micron Solutions said it named William Laursen, the former sales & strategy EVP at the Coghlin Cos., to be its new president & CEO, effective Nov. 29. Former chief executive Salvatore Emma Jr. is slated to assume the COO role at that time, when he’s also due to resign from the board at Micron, formerly known as Arrhythmia Research Technologies.
Read more
David Kaysen, the former CEO of Uroplasty (now Cogentix Medical), was named managing director & CEO of Medibio (ASX:MEB) .
Read more
- Meynadier out, Lobinsky in as Eos Imaging CEO; Worrall named CFO
- Intersect ENT names COO, strategy chief
- Stereotaxis names Barry as legal, compliance chief
- Restoration Robotics appoints former Zeltiq exec Sullivan as interim chief commercial officer
- Surmodics looks to Sides for marketing chief
- Cantel Medical promotes Haydon to SVP, medical GM
The post CardioMech taps medtech vet Nehm for CEO | Personnel Moves, November 5, 2018 appeared first on MassDevice.
from MassDevice https://ift.tt/2zvKEv1
Cap comentari:
Publica un comentari a l'entrada